Canada Contraceptive Market Overview, 2030

The contraceptive market in Canada plays a vital role in ensuring reproductive health, family planning, and the prevention of unintended pregnancies, all of which contribute significantly to global health. With an increasing emphasis on individual reproductive rights, Canada is experiencing a shift towards a broader range of contraceptive options to meet diverse needs. Contraceptive methods are crucial in providing individuals with control over their fertility, empowering them to make informed decisions about family planning. Not only does this enhance personal autonomy, but it also plays a pivotal role in reducing the incidence of unplanned pregnancies, which in turn lowers healthcare costs and promotes healthier families. Increasing health awareness among Canadians has spurred a positive shift toward the adoption of various contraceptive technologies and solutions. The global contraceptive market is forecasted to see robust growth in the coming years, driven by increasing awareness, improved access to healthcare, and technological advancements. Canada, as part of the North American region, reflects these trends with growing demand for non-pill contraceptives like IUDs, implants, and injectables, which offer longer-lasting protection compared to traditional oral contraceptives. Innovations in smart contraceptives, such as mobile apps that track fertility cycles or hormonal wearables, are also gaining attention in Canada. The global movement towards male contraception is slowly gaining traction, with researchers exploring hormonal and non-hormonal male birth control options.

According to the research report “Canada Contraceptive Market Overview, 2030,"" published by Bonafide Research, the Canada Contraceptive market is expected to reach a market size of more than USD 1.60 Billion by 2030. Cultural and religious beliefs significantly influence the adoption of contraceptive methods in various regions, including Canada. While Canada is generally progressive in terms of access to contraception, certain cultural nuances and religious beliefs may affect how different communities embrace contraceptive options. In more conservative or religious communities, there can be resistance to contraceptive use due to moral objections, creating barriers to widespread adoption. For instance, some faith-based communities may oppose hormonal contraception, such as the pill, or methods that interrupt the natural reproductive process, like IUDs. Contraceptive access is deeply linked to women’s empowerment. In Canada, as in other countries, access to contraception empowers women to make decisions about their careers, families, and personal health, contributing to gender equality. Policies promoting free or subsidized access to contraception, such as provincial family planning programs, have shown a positive impact on women's participation in the workforce and their ability to manage their reproductive health. International family planning initiatives, backed by organizations like the United Nations and World Health Organization, have made strides in ensuring that women in low- and middle-income countries, as well as marginalized groups in developed nations like Canada, can access affordable contraception. The involvement of healthcare providers, pharmaceutical companies, and digital health companies is integral to breaking down these barriers and offering diverse contraceptive options. Major players in the Canadian contraceptive market include companies like Pfizer, Merck, and Bayer, each of which holds a significant share of the market by providing both hormonal and non-hormonal solutions, such as oral contraceptives, IUDs, and implants.

Contraceptive drugs, such as oral contraceptives, injectables, and patches, continue to be popular due to their accessibility and effectiveness. Birth control pills, which are taken daily, remain the most widely used method, especially among young women. These pills contain hormones that prevent ovulation, making them a convenient option for women who prefer a non-invasive, easily reversible form of contraception. Similarly, injectables offer a longer-term solution, with an injection administered every three months, providing hassle-free contraception for those who don’t want to manage daily medication. Contraceptive patches, worn on the skin and replaced weekly, are another popular alternative, offering continuous protection without the need for daily pill consumption. Contraceptive devices are gaining popularity due to their long-lasting, low-maintenance nature. The intrauterine device (IUD) is one of the most commonly used devices in Canada. IUDs are small T-shaped devices inserted into the uterus by a healthcare provider. They come in both hormonal and copper varieties, offering women a non-hormonal or hormonal solution to birth control. IUDs can last between 3 to 10 years, depending on the type, and require minimal upkeep, making them ideal for individuals who prefer not to manage daily or monthly contraception. Contraceptive implants, small rods inserted under the skin, offer long-term protection for up to five years. These implants release hormones that prevent pregnancy by inhibiting ovulation, providing a highly effective and discreet option for women.

The age group of 15 to 44 years forms the core demographic of contraceptive users in Canada, as this is the prime reproductive age for individuals making decisions around family planning and contraception. Within this group, younger women are typically more likely to use condoms, oral contraceptives, and emergency contraception. These methods offer easy access and are commonly recommended for sexually active individuals who may not yet be considering long-term solutions. In this group, education about safe sex and the prevention of sexually transmitted infections plays a critical role in contraceptive choices, and social media campaigns and healthcare provider guidance are increasingly shaping their decisions. As individuals within this age group move into their late twenties to early thirties, they often shift towards more long-term contraceptive options, such as IUDs, implants, and injectables, due to the convenience and reliability these methods offer. In contrast, individuals above the age of 44 years typically see a decline in contraceptive use as fertility declines with age. However, many women in this group still seek contraception, particularly for managing perimenopausal symptoms, irregular periods, or to prevent unwanted pregnancies, especially in the absence of permanent sterilization methods. For women above 44, options like hormonal IUDs or sterilization are popular choices due to their long-term nature and minimal maintenance. As more women are opting to have children later in life, contraception continues to play an essential role in family planning for older women, ensuring that they have effective options suited to their health status and life circumstances.

Female contraceptives, such as oral contraceptives, IUDs, implants, injectables, and patches, account for the majority of market share. For women, these methods provide effective, long-term options to control their reproductive health, allowing them to plan pregnancies, avoid unintended pregnancies, and manage menstrual cycles. Among these, oral contraceptives are the most widely used due to their ease of use and availability, although there has been a growing preference for longer-lasting, reversible methods like IUDs and implants in recent years. While women have traditionally shouldered the responsibility for contraception, there is a growing interest in male contraception. Historically, men have had limited options, primarily condoms and sterilization, to prevent pregnancies. Research into male contraceptive methods is expanding, and new products like hormonal contraceptive pills, non-hormonal male birth control, and injectables are slowly emerging as viable options. These new methods aim to provide men with more control over their reproductive health, creating a more equitable approach to contraception. The development of male contraceptives could significantly reshape how reproductive responsibility is shared in relationships. While male contraceptives are still in the early stages of development, their future potential to contribute to the contraceptive market is considerable. Male condoms remain one of the most accessible and commonly used forms of contraception in Canada, providing protection against both pregnancy and sexually transmitted infections. The growing interest in gender-inclusive contraceptive solutions indicates a shift toward shared responsibility in reproductive health. With increasing advancements in both female and male contraceptive options, there is potential for greater choice and control over reproductive decisions for both genders.

Retail pharmacies are the most widely used and easily accessible distribution channel for contraceptives, providing a broad range of products such as birth control pills, condoms, emergency contraception, and hormonal patches. These pharmacies are typically the first point of access for many individuals, due to their availability in most communities and their convenience. Consumers can purchase contraceptives over the counter or with a prescription, making retail pharmacies an essential channel for everyday contraceptive needs. Hospital pharmacies also play a critical role in the distribution of contraceptives, particularly for more specialized methods such as IUDs, implants, and injectables, which require professional healthcare provider administration. These products are typically prescribed after consultations with healthcare professionals who can assess an individual’s health status and recommend the most appropriate method. Hospital pharmacies often serve as a critical point of access for those seeking long-term, medically supervised contraception. Many women visit hospitals for consultations and prescriptions, ensuring that they receive personalized care tailored to their specific reproductive needs. The rise of online channels is rapidly transforming the contraceptive market in Canada. Digital platforms are making it easier for consumers to purchase contraceptives discreetly and conveniently from the comfort of their homes. Many online platforms now offer telehealth consultations, allowing individuals to consult with healthcare professionals remotely, receive prescriptions, and have their contraceptives delivered directly to their door. Other distribution channels, such as community clinics, NGOs, and government-funded programs, provide contraceptives at low or no cost to underserved populations. These channels are essential for improving access to contraception for marginalized groups and ensuring that individuals who might otherwise be unable to afford contraception still have access to reproductive healthcare.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Contraceptive Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Contraceptive Drugs
• Contraceptive Devices

By Age Group
• 15 - 44 years
• Above 44 years

By Gender
• Female
• Male

By Distribution Channels
• Retail pharmacies
• Hospital pharmacies
• Online channels
• Other distribution channels Show more